These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Active immunoprophylaxis to reduce clinical impact of Herpes Zoster and its complications].
    Author: Marino MG, Bagnato B, Torella I, Franco E.
    Journal: Ig Sanita Pubbl; 2009; 65(3):299-311. PubMed ID: 19629155.
    Abstract:
    Herpes Zoster is a painful cutaneous eruption caused by reactivation of Varicella Zoster Virus, years after primary infection. Approximately one third of the population, and more than 50% of persons older than 80, will present zoster in their lifetime. Zoster complications, particularly postherpetic neuralgia, are common and result in worsening health status and quality of life, with high direct and indirect costs. Licensed zoster vaccine, available in Italy in a next future, is efficacious in preventing virus reactivation and particularly in reducing complications.
    [Abstract] [Full Text] [Related] [New Search]